Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cognition Therapeutics
Cognition Therapeutics
Cognition Therapeutics Receives $6.6M from NIA to Study Elayta Synaptoprotective Mechanism of Action in Alzheimer's
CP Wire
Tue, 05/22/18 - 06:17 pm
Cognition Therapeutics
Elayta
NIH
grants
Alzheimer's disease
Cognition Therapeutics Receives $6.6M from NIA to Study Elayta Synaptoprotective Mechanism of Action in Alzheimer's
Tue, 05/22/18 - 06:16 pm
Cognition Therapeutics
Alzheimer's disease